Mohammad Al-Shabanah

Learn More
In an earlier study, we have demonstrated a high clinical and pathologic response rate of neoadjuvant paclitaxel (P) and cisplatin (C) for patients with locally advanced breast cancer (LABC). The current phase II study includes larger number of patients who had longer follow-up. A total of 126 consecutive patients with noninflammatory LABC (T2 >4 cm, T3 or(More)
PUBLICATIONS by members of the Medical Physics Unit : 2014 calendar year (x 61) (names of MPU staff members are underlined, students are indicated by †) 1. Detecting early preclinical Alzheimer's disease via cognition, neuropsychiatry, and neuroimaging: Qualitative review and recommendations for testing, J. Alzheimer's Disease 42(4), S375-82 (2014). 2.(More)
Among 45 variants in 11 genes, HDM2 promoter polymorphisms emerge as new candidate biomarker associated with radiation toxicity Abstract Due to individual variations in radiosensitivity, biomarkers are needed to tailor radiation treatment to cancer patients. Since single nucleotide polymorphisms (SNPs) are frequent in human, we hypothesized that SNPs in(More)
  • 1